Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Regulus Therapeutics Inc. - Common Stock (NQ:RGLS)

8.160 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	8.160
Bid (Size)	8.010 (4)
Ask (Size)	8.150 (5)
Prev. Close	8.160
Today's Range	8.160 - 8.160
52wk Range	0.8301 - 8.345
Shares Outstanding	87,040,335
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of Shareholders

May 15, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (Nasdaq - XAGE), Southern States Bancshares, Inc. (Nasdaq

May 15, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Performance

YTD	+423.1%	+423.1%
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	+3.4%	+3.4%
1 Year	+482.9%	+482.9%

More News

REGULUS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Regulus Therapeutics Inc. - RGLS

May 04, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗

May 01, 2025

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

May 01, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead ↗

May 01, 2025

Via Stocktwits

Wednesday's session: top gainers and losers ↗

April 30, 2025

Via Chartmill

Top stock movements in today's session. ↗

April 30, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

April 30, 2025

Via Chartmill

Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher ↗

April 30, 2025

Via Benzinga

Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million ↗

April 30, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

April 30, 2025

Via Chartmill

S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results ↗

April 30, 2025

Via Benzinga

Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis ↗

April 30, 2025

Via Stocktwits

RGLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Regulus Therapeutics Inc. Is Fair to Shareholders

April 30, 2025

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 30, 2025

Via Benzinga

Shareholder Alert: The Ademi Firm Investigates Whether Regulus Therapeutics Inc. Is Obtaining a Fair Price for Its Public Shareholders

April 30, 2025

From Ademi & Fruchter LLP

Via Business Wire

Top movers analysis one hour before the close of the markets on 2025-04-28: top gainers and losers in today's session. ↗

April 28, 2025

Via Chartmill

These stocks are moving in today's session ↗

April 28, 2025

Via Chartmill

These stocks have an unusual volume in today's session ↗

April 01, 2025

Via Chartmill

Top stock movements in today's session. ↗

March 27, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 27, 2025

Via Benzinga

Regulus Therapeutics Stock Shoots Higher After Positive Results From Investigational Drug For Rare Type Of Kidney Disease ↗

March 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 27, 2025

Via Benzinga

Frequently Asked Questions

Is Regulus Therapeutics Inc. - Common Stock publicly traded?

Yes, Regulus Therapeutics Inc. - Common Stock is publicly traded.

What exchange does Regulus Therapeutics Inc. - Common Stock trade on?

Regulus Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Regulus Therapeutics Inc. - Common Stock?

The ticker symbol for Regulus Therapeutics Inc. - Common Stock is RGLS on the Nasdaq Stock Market

What is the current price of Regulus Therapeutics Inc. - Common Stock?

The current price of Regulus Therapeutics Inc. - Common Stock is 8.160

When was Regulus Therapeutics Inc. - Common Stock last traded?

The last trade of Regulus Therapeutics Inc. - Common Stock was at 06/24/25 04:00 PM ET

What is the market capitalization of Regulus Therapeutics Inc. - Common Stock?

The market capitalization of Regulus Therapeutics Inc. - Common Stock is 710.25M

How many shares of Regulus Therapeutics Inc. - Common Stock are outstanding?

Regulus Therapeutics Inc. - Common Stock has 710M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.